Cimiracemates A-D, phenylpropanoid esters from the rhizomes of Cimicifuga racemosa. (Q44177662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Cimiracemates A-D, phenylpropanoid esters from the rhizomes of Cimicifuga racemosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

1 reference

1 reference

methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

1 reference

caffeic acid methyl ester

1 reference

[3-(3,4-Dihydroxyphenyl)-2-oxopropyl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

1 reference

[(3S)-3-(3,4-dihydroxyphenyl)-3-methoxy-2-oxopropyl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

1 reference

1 reference

1 reference

1 reference

1 reference

[(3S)-3-(3,4-dihydroxyphenyl)-3-methoxy-2-oxopropyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

1 reference

1 reference

[3-(3,4-Dihydroxyphenyl)-2-oxopropyl] 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

1 reference

1 reference

Cimicifuga racemosa

1 reference

2-[[2-Hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.01,18.03,17.04,14.07,12.012,14]tetracosan-9-yl]oxy]oxane-3,4,5-triol

inferred from title

1 reference

[8-(3,3-Dimethyloxiran-2-yl)-10,11-dihydroxy-4,6,12,17,17-pentamethyl-18-(3,4,5-trihydroxyoxan-2-yl)oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl] acetate

1 reference

2-(2,3-dihydroxypropyl)hexadecanoic acid

1 reference

2-[2-Hydroxy-3,8,8,17,19-pentamethyl-9-(3,4,5-trihydroxyoxan-2-yl)oxy-23,24-dioxaheptacyclo[19.2.1.01,18.03,17.04,14.07,12.012,14]tetracosan-22-yl]propan-2-yl acetate

1 reference

[1,4',6',12',17',17'-Hexamethyl-2-oxo-18'-(3,4,5-trihydroxyoxan-2-yl)oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate

1 reference

[6-[[15-[4-Acetyloxy-4-(3,3-dimethyloxiran-2-yl)butan-2-yl]-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-4,5-dihydroxyoxan-3-yl] acetate

1 reference

1 reference

2-(1,4',6',12',17',17'-Hexamethylspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docos-13-ene]-18'-yl)oxyoxane-3,4,5-triol

1 reference

[8-(3,3-Dimethyloxiran-2-yl)-10,11,18-trihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl] acetate

1 reference

2-[(2-Hydroxy-3,8,8,17,19-pentamethyl-22-prop-1-en-2-yl-23,24-dioxaheptacyclo[19.2.1.01,18.03,17.04,14.07,12.012,14]tetracosan-9-yl)oxy]oxane-3,4,5-triol

1 reference

Cimicidanol 3-O-alpha-L-arabinoside

1 reference

[2-Hydroxy-3,8,8,17,19-pentamethyl-22-prop-1-en-2-yl-9-(3,4,5-trihydroxyoxan-2-yl)oxy-23,24-dioxaheptacyclo[19.2.1.01,18.03,17.04,14.07,12.012,14]tetracosan-16-yl] acetate

1 reference

[18'-(5-Acetyloxy-3,4-dihydroxyoxan-2-yl)oxy-2-hydroxy-1,4',6',12',17',17'-hexamethylspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate

1 reference

[1,4',6',12',17',17'-Hexamethyl-18'-(3,4,5-trihydroxyoxan-2-yl)oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate

1 reference

[6-[[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl octadeca-9,12-dienoate

1 reference

[18'-(3-Acetyloxy-4,5-dihydroxyoxan-2-yl)oxy-2-hydroxy-1,4',6',12',17',17'-hexamethylspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate

1 reference

[1,4',6',12',17',17'-Hexamethyl-18'-(3,4,5-trihydroxyoxan-2-yl)oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docos-14-ene]-3'-yl] acetate

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Hongjie Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

6

Norman R Farnsworth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Daniel S Fabricant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Zhi-Zhen Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Harry H S Fong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

October 2002

1 reference

16 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

409-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

Polyacetylenverbindungen, 243. Über die Inhaltsstoffe vonCoreopsis parvifolia Blake

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Cimiracemosides I-P, new 9,19-cyclolanostane triterpene glycosides from Cimicifuga racemosa

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Isolation, structure elucidation, and absolute configuration of 26-deoxyactein from Cimicifuga racemosa and clarification of nomenclature associated with 27-deoxyactein

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Reclassification of Actaea to Include Cimicifuga and Souliea (Ranunculaceae): Phylogeny Inferred from Morphology, nrDNA ITS, and cpDNA trnL-F Sequence Variation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Studies on the endocrine effects of the contents of Cimicifuga racemosa:

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Studies on the endocrine effects of the contents of Cimicifuga racemosa 2. In vitro binding of compounds to estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

Liquid chromatographic–electrospray mass spectrometric study of the phthalides of Angelica sinensis and chemical changes of Z-ligustilide

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2802%2900209-1

7 January 2021

10.1016/S0031-9422(02)00209-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377235%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference